Gene · 10155
Papers3,480
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,480
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| KAP1 negatively regulates RNA polymerase II elongation kinetics to activate signal-induced transcription. | bioRxiv | 2024 | 38746145 | PubTator, text mining | PubMed |
| KAP1 stabilizes MYCN mRNA and promotes neuroblastoma tumorigenicity by protecting the RNA m6A reader YTHDC1 protein degradation. | J Exp Clin Cancer Res | 2024 | 38745192 | PubTator, text mining | PubMed |
| TIF1β activates leukemic transcriptional program in HSCs and promotes BCR::ABL1-induced myeloid leukemia. | Leukemia | 2024 | 38734786 | PubTator, text mining | PubMed |
| Gene regulatory network analysis identifies MYL1, MDH2, GLS, and TRIM28 as the principal proteins in the response of mesenchymal stem cells to Mg2+ ions. | Comput Struct Biotechnol J | 2024 | 38689715 | PubTator, text mining | PubMed |
| [Expression and prognostic significance of KAP1 gene in malignant pleural mesothelioma]. | Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi | 2024 | 38677988 | PubTator, text mining | PubMed |
| Attraction and disruption: how loop extrusion and compartmentalisation shape the nuclear genome. | Curr Opin Genet Dev | 2024 | 38636335 | PubTator, text mining | PubMed |
| 'One way, or another, I'm gonna find ya': miR-221-3p finds its targets via small extracellular vesicles. | Haematologica | 2024 | 38634128 | PubTator, text mining | PubMed |
| Orthogonal IMiD-Degron Pairs Induce Selective Protein Degradation in Cells. | bioRxiv | 2024 | 38559242 | PubTator, text mining | PubMed |
| TRIM27 Promotes Endothelial Progenitor Cell Apoptosis in Patients with In-Stent Restenosis by Ubiquitinating TBK1. | Appl Biochem Biotechnol | 2024 | 38558276 | PubTator, text mining | PubMed |
| TRIM28-Mediated Excessive Oxidative Stress Induces Cellular Senescence in Granulosa Cells and Contributes to Premature Ovarian Insufficiency In Vitro and In Vivo. | Antioxidants (Basel) | 2024 | 38539841 | PubTator, text mining | PubMed |
| Roles of endogenous retroviral elements in the establishment and maintenance of imprinted gene expression. | Front Cell Dev Biol | 2024 | 38505259 | PubTator, text mining | PubMed |
| TRIM28 facilitates type I interferon activation by targeting TBK1. | Front Immunol | 2024 | 38495890 | Swiss-Prot, curated | PubMed |
| Endogenous retrovirus activation: potential for immunology and clinical applications. | Natl Sci Rev | 2024 | 38495812 | PubTator, text mining | PubMed |
| When the Embryo Meets the Endometrium: Identifying the Features Required for Successful Embryo Implantation. | Int J Mol Sci | 2024 | 38474081 | PubTator, text mining | PubMed |
| Structural basis for RAD18 regulation by MAGEA4 and its implications for RING ubiquitin ligase binding by MAGE family proteins. | EMBO J | 2024 | 38448672 | PubTator, text mining | PubMed |
| Epigenetic Restriction Factors (eRFs) in Virus Infection. | Viruses | 2024 | 38399958 | PubTator, text mining | PubMed |
| Macrophage-Related Gene Signatures for Predicting Prognosis and Immunotherapy of Lung Adenocarcinoma by Machine Learning and Bioinformatics. | J Inflamm Res | 2024 | 38348277 | PubTator, text mining | PubMed |
| Serum Proteomic Analysis Revealed Biomarkers for Eosinophilic Chronic Rhinosinusitis with Nasal Polyps Pathophysiology. | J Inflamm Res | 2024 | 38344304 | PubTator, text mining | PubMed |
| System biology approaches to identify hub genes linked with ECM organization and inflammatory signaling pathways in schizophrenia pathogenesis. | Heliyon | 2024 | 38322840 | PubTator, text mining | PubMed |
| Wilms tumour resulting from paternal transmission of a TRIM28 pathogenic variant-A first report. | Eur J Hum Genet | 2024 | 38282073 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10155/papers?page=15